Sarilumab plus methotrexate improves patient-reported outcomes in patients with active rheumatoid arthritis and inadequate responses to methotrexate: results of a phase III trial

Author(s):
Strand, V.; Kosinski, M.; Chen, C.I.; Joseph, G.; Rendas-Baum, R.; Graham, N.M.H.; Hoogstraten, H. van; Bayliss, M.; Fan, C.P.; Huizinga, T.; Genovese, M.C.
Published
2016
Publication type
Article / Letter to editor
Rheumatoid arthritisSarilumabPatient-reported outcomesInterleukin-6Fatigue
Date issued
2016-09-06
Language
English
Is part of
Arthritis Research and Therapy
hdl
1887/87924
doi
10.1186/s13075-016-1096-9